Australia’s most read investor-focused magazine for ASX-listed Tech & Biotech stocks
Trending Stories
6 November, 2024
Little Green Pharma (ASX: LGP) Hits Record Revenue, Expands European Reach and Cash Flow Positive for First Time
Little Green Pharma (ASX: LGP) has delivered a stellar September quarter, positioning itself as a strong contender in the increasingly competitive medicinal cannabis space. CEO Paul Long recently...
5 November, 2024
Airtasker (ASX: ART) Delivers Revenue Growth and Positive Cash Flow in Q1 FY25
Airtasker (ASX: ART), Australia’s leading marketplace for local services, has started FY25 on a high note, reporting strong growth across key metrics in its latest quarterly update. For the September...
5 November, 2024
Osteopore Teams Up with DKSH for Singapore Push in Orthopaedic Implants
ASX-listed regenerative medicine specialist Osteopore Limited (ASX: OSX) has announced a significant partnership with Swiss market expansion leader DKSH to distribute its orthopaedic products in...
5 November, 2024
Memphasys Raises $1.86 Million to Propel Clinical and Commercial Development of Reproductive Biotech Innovations
Memphasys Limited (ASX: MEM) announced today the completion of its Share Purchase Plan (SPP) and Placement Offer, successfully raising $1.857 million to accelerate the development and...
4 November, 2024
Imugene's VAXINIA Trial Reaches Two-Year Milestone for Bile Tract Cancer Patient Amid FDA Fast-Track Progress
Imugene Limited (ASX: IMU) has made significant strides in the fight against bile tract cancer, as announced today in an update on its VAXINIA oncolytic virus trial. The highlight: a patient in its...
Latest News
Latest Web & Podcasts
Book Now for the Next Edition
Reach real investors through TechInvest Magazine, distributed as an independent insert in The Australian Financial Review, online via www.techinvest.online as well as across investor-focused social media channels.
Book now for TechInvest Edition 4, coming in 2024 with many opportunities to showcase your Tech insights.
What you get:
- Article on your company written by a highly experienced writer or supplied by your company
- Approved article included in TechInvest and replicated on www.techinvest.online
- Two page ‘Company in Focus’ features receive prominent pointer on front page of magazine
- Copy of article (copyright free) for you to use for own marketing purposes
- 10 copies of magazine
Upcoming Webinars
RaaS Stock Take Webinar - Cash Converters
13 November, 2024 | AWST | ONLINE
RAAS Research Group welcomes investors to this Stock Take Webinar which will see one of our highly qualified analysts provide their “take” on a budding ASX-listed stock. The next Stock Take company...
RaaS Stock Take Webinar - Verbrec
15 November, 2024 | AWST | ONLINE
RAAS Research Group welcomes investors to this Stock Take Webinar which will see one of our highly qualified analysts provide their “take” on a budding ASX-listed stock. The next Stock Take company...